Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSPE1P26 is annotated as a pseudogene related to the heat shock protein family E member 1 (Hsp10), which is normally a small mitochondrial chaperonin protein involved in protein folding. Pseudogenes are typically genomic DNA sequences similar to normal genes but nonfunctional; they are generally not transcribed or translated, and do not code for functional proteins. In some cases, pseudogenes can have regulatory roles by generating non-coding RNAs or acting as microRNA decoys, but no such role is ascribed to HSPE1P26 specifically. It is not used as a therapeutic target, biomarker, nor does it have known pharmacological or pathological significance[2][4].\n\nSummary: HSPE1P26 is not a real or functional target—it's a pseudogene, so it is not an enzyme, receptor, transporter, or other protein class for which drugs are developed. There are no known drugs, biomarkers, functions, or disease roles directly linked to it. The correct classification is a nonfunctional pseudogene with no current therapeutic relevance[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family E (Hsp10) member 1 pseudogene 26 (HSPE1P26).